Eurofins Scient (OTCMKTS:ERFSF) Shares Gap Up – Still a Buy?

Eurofins Scient (OTCMKTS:ERFSF) gapped up prior to trading on Thursday . The stock had previously closed at $80.70, but opened at $84.5780. Eurofins Scient shares last traded at $85.00, with a volume of 814 shares.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. BNP Paribas Exane upgraded Eurofins Scient to an “outperform” rating in a research report on Monday, January 5th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Eurofins Scient in a report on Wednesday, October 29th. Finally, Citigroup reissued a “neutral” rating on shares of Eurofins Scient in a report on Wednesday, October 22nd. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold”.

Eurofins Scient Trading Up 5.6%

The company has a debt-to-equity ratio of 0.77, a current ratio of 1.26 and a quick ratio of 1.19. The business’s 50 day moving average is $73.34 and its two-hundred day moving average is $73.88.

Eurofins Scient Company Profile

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.